Company overview
eXmoor Pharma is a full-service CDMO specializing in cell and gene therapy manufacturing, offering end-to-end solutions from CMC strategy and process development to GMP production and facility design. Founded in 2004 and headquartered in Bristol, UK, the company supports innovators with over 20 years of consultancy experience, having completed 500+ projects for 150+ organizations. Their flexible GMP facility includes Grade C cleanrooms for viral vectors, autologous, and allogeneic therapies, with plans to expand to 200 employees by 2027.
eXmoor Pharma is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include cell therapy cdmo, gene therapy manufacturing, gmp cleanrooms, cmc strategy, cgt development.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with eXmoor Pharma include Cdmo — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.exmoorpharma.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- cell therapy cdmo, gene therapy manufacturing, gmp cleanrooms, cmc strategy, cgt development
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What services does eXmoor Pharma offer for cell and gene therapy?
- eXmoor provides end-to-end services including CMC strategy, process and analytical development, GMP manufacturing, and facility design to support therapy development from concept to commercialization.
- What are eXmoor Pharma's GMP manufacturing capabilities?
- Their Bristol facility features four independent Grade C cleanrooms for viral vector, autologous, and allogeneic cell therapies, plus fill-finish areas and QC labs for scalable, compliant production.
- Where is eXmoor Pharma located and what is their experience?
- Headquartered in Bristol, UK, eXmoor was founded in 2004, specialized in CGT since 2007, and has completed over 500 projects for 150+ organizations with 80 employees growing to 200 by 2027.
Related editorial coverage
- ASGCT 2026: Gene Therapy Manufacturing Innovations Emerge
- ASGCT 2026: Gene Therapy Manufacturing Advances to Watch
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
Explore lab tools and QA/QC resources for R&D teams.
